Related Experiment Videos
[Breast cancer]
1Servicio de Oncología Médica y Quimioterapia, Hospital Rafael Hernández, David, Chiriquí.
Insights
This study on breast cancer patients found survival rates decrease significantly with advanced stages. Stage I patients had an 83.3% survival rate, while Stage IIIB had 0%.
Area of Science:
- Oncology
- Clinical Medicine
Context:
- Review of 31 female breast cancer patients at Dr. Rafael Hernández Hospital (1988-1990).
- Average patient age was 51.9 years.
- Staging distribution: Stage I (41.9%), Stage II (29%), Stage IIIA (16.1%), Stage IIIB (12.8%).
Purpose:
- To analyze clinical characteristics and survival outcomes of breast cancer patients.
- To evaluate the impact of disease stage on patient prognosis.
Summary:
- Most patients (74%) received modified radical mastectomy, radiation, and hormonal therapies.
- Systemic cytotoxic therapy was administered to 77% of patients.
- Forty-eight-month survival rates varied by stage: Stage I (83.3%), Stage II (66%), Stage IIIA (40%), Stage IIIB (0%).
Impact:
- Highlights the critical role of early breast cancer detection and treatment.
- Demonstrates a strong correlation between advanced stage at diagnosis and reduced survival.
- Informs treatment strategies and resource allocation for breast cancer care in similar settings.
Abstract:
The authors reviewed the clinical records of 31 patients with carcinoma of the breast diagnosed at the Dr. Rafael Hernández Hospital in Chiriquí from January 1988 to December 1990. All the patients were women and the average age was 51.9 years. 41.9% of the patients were classified Stage 1; 29%, Stage 2; 16.1%, Stage IIIA; and 12.8%, Stage IIIB. 74% of the patients were treated with a modified radical mastectomy, radiation and hormonal therapies. Systemic cytotoxic therapy was given to 77% of the patients. Total survival 48 months after diagnosis was 83.3% in patients at Stage I; 66%, at Stage II; 40%, at Stage IIIA; and 0%, in patients at Stage IIIB.